Chelating polymer modified monoclonal antibodies for radioimmunodiagnostics and radioimmunotherapy
- 1 May 1993
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 24 (1-3) , 111-118
- https://doi.org/10.1016/0168-3659(93)90171-z
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Terminal-modified polylysine-based chelating polymers: highly efficient coupling to antibody with minimal loss in immunoreactivityBioconjugate Chemistry, 1991
- Succinylated polylysine as a possible link between an antibody molecule and deferoxamineBioconjugate Chemistry, 1990
- Antibody-linked chelating polymers for immunoimaging in vivoJournal of Controlled Release, 1990
- Modification of monoclonal antimyosin antibody: Enhanced specificity of localization and scintigraphic visualization in acute experimental myocardial infarctionJournal of Molecular and Cellular Cardiology, 1989
- Monoclonal Antibody Modification with Chelate-Linked High-Molecular-Weight Polymers: Major Increases in Polyvalent Cation Binding without Loss of Antigen BindingHybridoma, 1987
- High-level conjugation of chelating agents onto immunoglobulins: use of an intermediary poly(l-lysine)-diethylenetriaminepentaacetic acid carrierBiochimica et Biophysica Acta (BBA) - General Subjects, 1986
- Monoclonal antibodies labeled with polymeric paramagnetic ion chelatesMagnetic Resonance in Medicine, 1986
- Preparation of 67Ga-labelled human IgG and its Fab fragments using desferoxamine as chelating agentEuropean Journal of Nuclear Medicine and Molecular Imaging, 1985
- Radioimmunodetection and RadioimmunotherapyCancer Investigation, 1984
- Monoclonal Antibody to Cardiac Myosin: Imaging of Experimental Myocardial InfarctionHybridoma, 1984